Perspective Therapeutics, Inc. — Director's Dealing 2014

Jul 8, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2014-06-17

Reporting Person: Ragle Brien (CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-17	Stock Options	$2.46	A	20000	Acquired	2024-06-16	Common Stock (20000)	Direct

Footnotes

F1: right to buy.

F2: 1/3 will vest on 6/17/15, 1/3 will vest on 6/17/16 and 1/3 will vest on 6/17/17.